Both in Surgical Instruments
Avita Medical vs Neuropace
Over the past year RCEL returned +326.4% and NPCE returned +24.7%; their daily moves had a correlation of 0.16.
RCEL +326.4% NPCE +24.7%Growth of $1, one year, split-adjusted
| Metric | RCEL | NPCE |
|---|---|---|
| Price | $15.65 | $12.30 |
| Market cap | $484.0M | $422.2M |
| Today | −6.34% | −5.46% |
| 1 month | +30.3% | −6.5% |
| 6 months | +252.5% | −27.9% |
| Year to date | +353.6% | −20.3% |
| 1 year | +324.1% | +21.4% |
| Revenue growth (YoY) | +17.8% | +17.1% |
| Gross margin | 81.9% | 82.8% |
| Net margin | −35.3% | −27.2% |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 4.3× |
| Net cash | -$35.5M | -$7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 119.9% | 42.5% |
| Short % of float | 9.4% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).